Using Machine Learning and Biomarkers for Early Detection of Delayed Cerebral Ischemia

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-110
SponsorSahlgrenska University Hospital

About this trial

The overall goal of this project is to determine if machine learning and analysis of neurospecific biomarkers can enable early detection of upcoming or ongoing cerebral ischaemia in patients suffering from subarachnoid haemorrhage with altered consciousness due to cerebral injury or sedation. Analyses of heart rate variability, electroencephalgraphy,nearinfrared spectroscopy, cerebral autoregulation, and brain injury specific biomarkers in blood and cerebrospinal fluid will be performed.

Eligibility criteria

Qualifiers

None

Disqualifiers

Unable to consent,

Cardiac arrythmia,

Previous brain damage

Trial design

Treatments tested in this trial

  • No intervention, observational study

Treatment groups

1,500 Participants
are divided into 2 treatment groups